Abdulhameed Bakreen1,2, Miia Juntunen3,4, Yannick Dunlop1, Irene F Ugidos2, Tarja Malm2, Susanna Miettinen3,4, Jukka Jolkkonen1,2. 1. Department of Neurology, University of Eastern Finland, FI-70210 Kuopio, Finland. 2. A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70150 Kuopio, Finland. 3. Faculty of Medicine and Health Technology, Tampere University, P.O. Box 607, FI-33014 Tampere, Finland. 4. Research, Development and Innovation Centre, Tampere University Hospital, P.O. Box 2000, FI-33521 Tampere, Finland.
Abstract
Microglia are involved in the post-stroke immunomodulation of brain plasticity, repair, and reorganization. Here, we evaluated whether adipose-tissue-derived mesenchymal stem cells (ADMSCs) and/or rehabilitation improve behavioral recovery by modulating long-term perilesional inflammation and creating a recovery-permissive environment in a rat model of ischemic stroke. METHODS: A two-way mixed lymphocyte reaction was used to assess the immunomodulatory capacity of ADMSCs in vitro. Two or 7 days after permanent middle cerebral artery occlusion (pMCAO), rats were intravenously administered ADMSCs or vehicle and housed in a standard or enriched environment (EE). Behavioral performance was assessed with a cylinder test, then we performed stereological and ImageJ/Fiji quantifications of ionized calcium-binding adaptor molecule 1 (Iba1) cells and blood-brain barrier (BBB) leakage. RESULTS: Human ADMSCs were immunosuppressive in vitro. The cylinder test showed partial spontaneous behavioral recovery of pMCAO rats, which was further improved by combined ADMSCs and housing in EE on days 21 and 42 (p < 0.05). We detected an ischemia-induced increase in numbers, staining intensity, and branch length of Iba1+ microglia/macrophages as well as BBB leakage in the perilesional cortex. However, these were not different among pMCAO groups. CONCLUSION: Combined cell therapy and rehabilitation additively improved behavioral outcome despite long-term perilesional microglia presence in stroke rats.
Microglia are involved in the post-stroke immunomodulation of brain plasticity, repair, and reorganization. Here, we evaluated whether adipose-tissue-derived mesenchymal stem cells (ADMSCs) and/or rehabilitation improve behavioral recovery by modulating long-term perilesional inflammation and creating a recovery-permissive environment in a rat model of ischemic stroke. METHODS: A two-way mixed lymphocyte reaction was used to assess the immunomodulatory capacity of ADMSCs in vitro. Two or 7 days after permanent middle cerebral artery occlusion (pMCAO), rats were intravenously administered ADMSCs or vehicle and housed in a standard or enriched environment (EE). Behavioral performance was assessed with a cylinder test, then we performed stereological and ImageJ/Fiji quantifications of ionized calcium-binding adaptor molecule 1 (Iba1) cells and blood-brain barrier (BBB) leakage. RESULTS:Human ADMSCs were immunosuppressive in vitro. The cylinder test showed partial spontaneous behavioral recovery of pMCAOrats, which was further improved by combined ADMSCs and housing in EE on days 21 and 42 (p < 0.05). We detected an ischemia-induced increase in numbers, staining intensity, and branch length of Iba1+ microglia/macrophages as well as BBB leakage in the perilesional cortex. However, these were not different among pMCAO groups. CONCLUSION: Combined cell therapy and rehabilitation additively improved behavioral outcome despite long-term perilesional microglia presence in strokerats.
Authors: Nikola Sladojevic; Svetlana M Stamatovic; Allison M Johnson; Jennifer Choi; Anna Hu; Sophie Dithmer; Ingolf E Blasig; Richard F Keep; Anuska V Andjelkovic Journal: J Neurosci Date: 2018-11-30 Impact factor: 6.167
Authors: Matthias Schilling; Michael Besselmann; Marcus Müller; Jan K Strecker; E Bernd Ringelstein; Reinhard Kiefer Journal: Exp Neurol Date: 2005-09-08 Impact factor: 5.330
Authors: Rachna S Pandya; Lijuan Mao; Hua Zhou; Shuanhu Zhou; Jiang Zeng; A John Popp; Xin Wang Journal: Cent Nerv Syst Agents Med Chem Date: 2011-06-01
Authors: Rodney M Ritzel; Anita R Patel; Jeremy M Grenier; Joshua Crapser; Rajkumar Verma; Evan R Jellison; Louise D McCullough Journal: J Neuroinflammation Date: 2015-05-29 Impact factor: 8.322
Authors: Mari Carmen Gómez-de Frutos; Fernando Laso-García; Luke Diekhorst; Laura Otero-Ortega; Blanca Fuentes; Jukka Jolkkonen; Olivier Detante; Anaick Moisan; Arturo Martínez-Arroyo; Exuperio Díez-Tejedor; María Gutiérrez-Fernández Journal: Stem Cell Res Ther Date: 2019-07-17 Impact factor: 6.832
Authors: Cynthia S Samary; Alane B Ramos; Lígia A Maia; Nazareth N Rocha; Cíntia L Santos; Raquel F Magalhães; Amanda L Clevelario; Pedro M Pimentel-Coelho; Rosália Mendez-Otero; Fernanda F Cruz; Vera L Capelozzi; Tatiana P T Ferreira; Thea Koch; Marcelo Gama de Abreu; Claudia C Dos Santos; Paolo Pelosi; Pedro L Silva; Patricia R M Rocco Journal: Crit Care Date: 2018-10-05 Impact factor: 9.097